Results 61 to 70 of about 13,415 (150)
Pediatric Dermatology, EarlyView.ABSTRACT Atopic dermatitis (AD) is a common and burdensome disease. Treatment options for pediatric and adolescent patients (< 18 years old) with moderate‐to‐severe AD are limited, and real‐world data on disease burden are lacking. This study examined patient‐reported disease burden and treatments in pediatric and adolescent patients to identify ...
Lawrence F. Eichenfield +7 more
wiley +1 more source
The Frontal Fibrosing Alopecia Syndrome: How a Single Word Name Change Might Change So Much
International Journal of Dermatology, EarlyView.
Jeffrey Donovan
wiley +1 more source
Clinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1171-1174, May 2025.Japan's conditional/time‐limited early approval program, initiated in 2014, aimed to advance regenerative medicine by expediting market access. However, the withdrawal of autologous skeletal myoblast sheets (Heartsheet) due to ineffectiveness raises concerns about the balance between rapid approval and scientific integrity.
Hayase Hakariya +3 more
wiley +1 more source
Corticotrophin and vitiligo (preliminary observations) [PDF]
, 1976 B. B. Gokhale, Tara B Gokhale
openalex +1 more source
Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
MedComm, Volume 6, Issue 5, May 2025.This review probed into the immune factors in the pathogenesis of AA, focusing on the small molecule drugs and biologics for the treatment of AA, and anticipated the research direction in terms of the pathogenesis and targeted therapy of AA. It aims to emphasize the necessity for further exploration of its immunological pathogenesis and therapeutic ...
Tianyou Ma +7 more
wiley +1 more source
Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2495-2506, May 2025.Abstract Aims This study surveyed individuals and caregivers of children who received teplizumab at stage 2 type 1 diabetes (T1D) to garner real‐world experiences and their health outlook for the future following treatment with the first approved disease‐modifying immune therapy for delaying the onset of Stage 3 T1D.
Holly K. O'Donnell +10 more
wiley +1 more source
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Khaled Ezzedine +10 more
wiley +1 more source
Premature hair graying: a multifaceted phenomenon
International Journal of Dermatology, Volume 64, Issue 5, Page 819-829, May 2025.Abstract Premature hair graying (PHG) is the early loss of natural hair color, influenced by genetic, biological, and environmental factors. This review discusses the significant psychological impacts of PHG and explores its underlying mechanisms, related health conditions, and available treatments.
Deesha D. Desai +9 more
wiley +1 more source